Chemotherapy for Lung Cancer

The medical oncologists in our Thoracic Cancer Program are among few in the country who specialize in thoracic cancer. That means significant advantages for our patients in terms of knowledge and expertise in treating this challenging disease.

Because so many factors affect how a chemotherapy plan is developed, our expertise and national role in research is invaluable. There are no set “menus” to follow, only established guidelines. Our medical oncologists consider factors such as the patient’s overall health, personal preferences and tolerance of different side effects. 

They then consider the dosage of the drugs; what combinations of drugs to use; how many different drugs to use; how frequently to administer them; whether to combine the chemotherapy with radiation therapy; and whether the drugs should be given before, after or concurrently with radiation therapy. Our medical oncologists are also part of our regular tumor boards, and work closely with all of our thoracic cancer specialists to determine the best treatment plan for each person.

Clinical Trials in Chemotherapy

Clinical trials are an important part of every area of lung cancer treatment, and chemotherapy studies are being conducted almost continuously. At Froedtert & the Medical College there are opportunities for patients to receive new chemotherapy drugs as part of clinical studies for almost every stage of lung cancer. These drugs of the future are not otherwise available in the community. Patients with lung cancer are especially encouraged to explore clinical trials.

Our medical oncologists are involved in designing national research studies. They also participate in other studies that look at the role of chemotherapy in treating lung cancer. The Thoracic Cancer Program team belongs to several cancer cooperative groups, where large cancer centers nationally have joined together to be part of a network to carry out large clinical studies.

Studies examine such questions as what different combinations of chemotherapy drugs work best; what combinations of chemotherapy and radiation therapy work best; how many drugs to combine; how frequently to give treatments and more. Many of the trials we participate in are Phase II studies, which are close to being approved as standard treatments. We also participate in many Phase III trials, which test standard accepted treatments against one another or test a standard treatment against something a bit newer. See Clinical Trials Basics to learn more.

Types of Lung Cancer and Chemotherapy Treatments Options

Chemotherapy is the treatment backbone for a significant number of lung cancer patients. Once the stage of the cancer is known, a medical oncologist determines the most appropriate chemotherapy drugs. Some drugs can target certain mutations in the cancer gene, increasing their effectiveness and likelihood of response.

Small cell lung cancer is sensitive to chemotherapy and responds so well that surgery is rarely a part of the treatment plan. Established guidelines recommend roughly five or six different chemotherapy drugs as possible treatments for small cell lung cancer.

The standard treatment approach for small cell lung cancer that has not spread is chemotherapy and radiation given at the same time.

More advanced stages are generally treated with chemotherapy first and may be followed by radiation therapy to the chest, the brain, and other sites of disease depending on the response to chemotherapy and symptoms.

Non-small cell lung cancer has more subtypes and more diverse treatment options. Currently, 10 - 12 chemotherapy drugs are recommended for treating non-small cell lung cancer. In general, all of the subtypes are treated following the same guidelines.

If lung cancer is confined to the lung (Stage I) and surgically removed, chemotherapy is sometimes given to prevent recurrence. This is considered curative chemotherapy.

Chemotherapy is also used for Stages II and III for lung cancer that is confined to the chest. Chemotherapy can be given in combination with radiation and surgery when complete removal and curative treatment appears possible.

Doctors will treat cancer that has spread, or is likely to spread differently than cancer that is confined to the lung. Occasional isolated single areas of spread (oligometastases) are treated aggressively with surgery and a combination of radiation and chemotherapy. If the cancer has spread (metastasized) to other parts of the body such as the liver, brain or elsewhere (Stage IV), chemotherapy is given to relieve symptoms and prolong life. Today, the side effects of chemotherapy — nausea and vomiting — are greatly reduced, so benefits from chemotherapy are much greater than in the past.

Appointments

For lung and thoracic cancer treatment:

  • 414-805-0505
Request AppointmentView Treatment Team

Locations

Clinical Cancer Center, Froedtert Hospital 9200 W. Wisconsin Ave.
Milwaukee, WI 53226

Cancer Network